BENEFICIAL EFFECT OF FLAXSEED AND FLAXSEED OIL BY ADJUSTING OMEGA6:OMEGA3 RATIO ON LIPID METABOLISM IN HIGH CHOLESTEROL DIET FED RATS

نوع المستند : مقالات علمیة محکمة

المؤلفون

قسم علوم الأغذية ، کلية الزراعة ، جامعة القاهرة ، الجيزة ، مصر

المستخلص

Hypercholesterolemia is one of the major risk factors that precipitate coronary heart disease and atherosclerosis. abnormal lipid metabolism is a main cause of dyslipidemia, which is a major risk factor for cardiovascular disease, obesity, cholestasis, and overall mortality. It is well known that diet plays an important role in the control of cholesterol homeostasis . Many studies reported that flaxseed may have protective effect against diseases like cardiovascular diseases CVD, reducing the risk of cancers, reducing the incident and progress of diabetes .High omega-6/omega-3 ratio intake promotes development of many chronic diseases like cardiovascular disease, cancer, inflammatory and autoimoune disease, rheumatoid arthritis, asthma. Accordingly, the purpose of the present study was to investigate the effect of flaxseed and flaxseed  oil against high cholesterol diet induced hypercholesterolemia in rats by adjusting ω6 :ω3ratio(2.5:1),. Also, to determine whether flaxseed  or flaxseed  oil when administered to hypercholesterolemic induced-rats beneficial for  treatment of hypercholesterolemia complications. Animals(40 rats) were divided randomly into 4 equal groups . G1 fed on basal diet (NC) , G2 fed on HFD only(PC) . G3 and G4 fed on HFD with adjust ω6 :ω3 ratio(2.5:1)  by either flaxseed oil (FSO) or flaxseed( FS) . Blood samples were collected every 3 weeks for lipid parameters monitoring (serum total cholesterol (TC) ,triglycerides (TG) .high  density lipoprotein cholesterol (HDL) whereas  low  density lipoprotein cholesterol (LDL) was calculated . All samples (heart, kidney, spleen, lungs and brain, and liver) of each animal were weighted. liver and kidney were kept in formalin solution (10%) for the histopathological investigation
Results showed that ω6 :ω3 ratio was 1:3.8 in FS and 1:4.2 in FSO , while such ratio was 10:1 in grease .
The results showed that adjusting ω6 :ω3 ratio by FS or FSO led to significant high decrease of plasma cholesterol, triglyceride, LDL and to increase in HDL after 6 weeks . Results also indicated that the balance ratio of ω6 :ω3 led to decrease in weight of rats as such ratio is important for health and in the prevention and management of obesity. Histopathology examination of the organs tissue was in parallel with the biochemical results, as liver weight was higher in PC with a marked deterioration in liver tissue while treated groups showed alleviated histopathological alterations. Moreover , kidney tissues in treated group showed apparently normal glomeruli and tubular epithelium, similar to the negative control group. These results suggest that, flaxseed oil may be effective in controlling cholesterolemic status and improving dyslipidemia and has the potential in reducing cardiovascular complications due to hypercholesterolemia.
Key words: Omega6, Omega3, lipid profile, Liver, Hypercholesterolemia ,high cholesterol diet , rats weight , Flaxseed oil; , Flaxseed  

الكلمات الرئيسية

الموضوعات الرئيسية


Introduction

Hypercholesterolemia is one of the major risk factors that precipitate coronary heart disease and atherosclerosis.(Hussein et al., 2014)

Ruelet al., (2018): Familial hypercholesterolemia (FH) is an autosomal codominant lipoprotein disorder characterized by elevated low-density lipoprotein cholesterol (LDL-C) and high risk of premature atherosclerotic cardiovascular disease. Definitions for FH rely on complex algorithms that are on the basis of levels of total or LDL-C, clinical features, family history, and DNA analysis that are often difficult to obtain.

Molena-Fernandes et al., ( 2010) reported that  abnormal lipid metabolism is a main cause of dyslipidemia, which is a major risk factor for cardiovascular disease, obesity, cholestasis, and overall mortality. It is well known that diet plays an important role in the control of cholesterol homeostasis Cardiovascular diseases (CVD), mainly including atherosclerosis, hypertension, cardiac hypertrophy, myocardial infarction and heart failure, are the principal cause of death worldwide.( Ali et al.; 2017) . Although the development of pharmacotherapies to treat, CVD has contributed to a decline in cardiac mortality.( WHO. 2015 , Moss et al ., 2016 )

Many studies reported that flaxseed may have protective effect against diseases like cardiovascular diseases CVD, reducing the risk of cancers, reducing the incident and progress of diabetes  (Mishra,2016 and  Ali et al 2017) .

A number of investigations have demonstrated that diet supplemented with flaxseed oil has profound beneficial health effects in various pathologies. Flaxseed is also the richest source of lignans, which have been reported to have antioxidant and hypolipidemic effects (Newairy and Abdou, 2009). Flaxseed in the diet in animal studies has shown inhibit atherogenesis (Prasad, 2005) and protect during hyper-cholesterolemic conditions (Dupasquier et al., 2006).

Omega-6 and omega-3 polyunsaturated fatty acids (PUFAs) are essential fatty acids that must be derived from the diet, cannot be made by humans, and other mammals because of the lack of

endogenous enzymes for omega-3 desaturation . Due to agribusiness and modern agriculture western diets contain excessive levels of omega-6 PUFAs but very low levels of omega-3 PUFAs,leading to an unhealthy omega-6/omega-3 ratio of 20:1, instead of 1:1 that was during evolution in humans ( Simopoulos , 2016)

            High omega-6/omega-3 ratio intake promotes development of many chronic diseases like cardiovascular disease, cancer, inflammatory and autoimoune disease, rheumatoid arthritis, asthma, whereas increased intake of omega-3 fatty acids (reduced omega-6/omega-3 ratio) suppresses the effect ( Gupta et al , 2013)

Omega-3 PUFAs are primarily found in fish, especially in twait shad, salmon, tuna, and anchovies (Whelan & Rust, 2006). Another important source of PUFA is flaxseed obtained from Linum usitatissimum plants (Linaceae family), cropped mainly in Argentina, Brazil, Canada, China, India. and Turkey (SAMMOUR, 1999).

Accordingly, the purpose of the present study was to investigate the effect of flaxseed and flaxseed  oil against high cholesterol diet induced hypercholesterolemia in rats by adjusting ω6 :ω3ratio(2.5:1),. Also, to determine whether flaxseed  or flaxseed  oil when administered to hypercholesterolemic induced-rats beneficial for  treatment of hypercholesterolemia complications.

Materials & Methods

Experimental design and diet planning:

A total number of 40 adults Albino male normal rats, weighing 160- 190 g, obtained from Agriculture research institute .

All experiments were carried in the Agriculture research institute. Composition of experimental diets are shown in table(1).

Table (1):  Composition of Negative(basal diet) control (NC), positive                   (high cholesterol)control (PC), Flaxseed oil (FSO) and  Flaxseed( FS) diets (g /100g):

Ingredient

NC

PC

FSO

FS

Skim milk

36.4

36.4

36.40

32.99

Fiber

1

1

1

1

Starch

47.60

34.6

34.63

34.55

Salt mixture

4

4

4

4

Vit. Mixture

1

1

1

1

Corn oil

10

10

7.28

7.46

Flaxseed

-

-

-

6

flaxseed oil

-

-

2. 69

-

Grease

-

10.00

10.00

10.00

Cholesterol

-

2

2

2

Choline chloride

-

1

1

1

NC: Negative control                               PC: Positive control

FSO :Flaxseed Oil group                        FS :Flaxseed      

Diet in NC group contain 12% protein , 4%salt mixture , 1% vitamin mixture and 10%fat.

While diets in PC ,flaxseed( FS) and flaxseed oil groups contain 12% protein , 4%salt mixture , 1% vitamin mixture and 20%fat(10% plant oil from either corn oil, flaxseed or flaxseed oil and 10% grease as animal fat) 2% cholesterol and 1% choline chloride.

In all diets, skim milk was served as the main source of protein.

Both salt and vitamin mixtures were prepared according to A.O.A.C(2016).

Diets for both FS and FSO groups were designed with careful consideration, so that ω6 :ω3ratio was balanced in both experimental diets to a ratio of 2.4 and 2.5:1respectively by adding 6 %  flaxseed side to 7.46 g corn oil in flaxseed  group and 2.69 % flaxseed oil side to 7.28 g corn oil in flaxseed oil group .

ω6 :ω3ratio in PC group  was (29.9:1) as fat source was both corn oil and grease.

Chemical analysis

Chemical analysis of flaxseed, flaxseed oil  and grease (moisture , protein, fiber ,ash and fat), were analyzed according to A.O.AC. (2016). ω3and ω6content were also determined using gas chromatography according to ISO(1999).

Animal studies

Rats were fed on basal diet for two weeks as an adaption period. Rats were housed under controlled light (12: 12 light dark),

temperature were maintained at 25 °C and humidity at 60% respectively  with unlimited access to food and water . Rats weights were monitored daily for one week and then twice a week for the next 6 weeks .

All efforts were made to minimize pain and distress during animal husbandry  and  experiments assessments  .

Protocol is approved by the institutional Animal Care and Use Committee. Cairo University.

High fat high cholesterol diet:

High fat diets consists of 20%fat (10% grease + 10% plant oil), 2% cholesterol and 1% choline chloride were mixed with diet.

40 rats were divided into 4 groups (10rats each group):positive control group (PC)  , flaxseed oil group (FSO) and flaxseed group (FS),ten normal rats were fed basal diet and served as negative control group(NC) .Blood samples were collected every 3 weeks for lipid parameters monitoring (serum total cholesterol (TC) ,triglycerides (TG) .high  density lipoprotein cholesterol (HDL) whereas  low  density lipoprotein cholesterol (LDL) was calculated.  At the end of the experiment rats were sacrificed in a matched way so that the average length of the feeding period was the same in each group.

Biochemical assay:

Blood samples were obtained at intervals as mentioned before.

Before blood sampling ,rats were fasted for 16 hours. All blood samples were collected by capillary tube from vein pleascus in the eye and centrifuged at 3000 r.p.m. to obtain serum that was stored at -20oC until assayed for the determination of triglyceride , total cholesterol and high density lipoprotein (HDL).

Lipid profile;

Total cholesterol, triglycerides (TG), and high density lipoprotein-cholesterol (HDL-c) were determined as described by Thomas (1992), Fossati and Principle (1982), and Albers et al. (1983), respectively. Low density lipoprotein-cholesterol (LDL-c) and Very low density lipoprotein-cholesterol (VLDL-c) were calculated as mentioned by Lee and Nieman (1996).

Rat’s and organs weight:

Initial and final rat’s weight were monitored , weight gain was calculated  using the following formulas:

 Body weight gain (BWG) (g) = Final weight - Initial weight

  After sacrifying, organs(pancreas, kidney, heart , liver, spleen and brain) were weighted.

Histopathological examination:

Tissue samples of liver and kidney were removed carefully, and fixed in neutral buffered formalin 10%, dehydrated in ascending grade of alcohol, cleared and embedded in paraffin, sectioned at 5 μm thickness and stained by H & E and examined microscopically (Bancroft et al. (1996).

Statistical analysis:

Results were statistically analyzed by the L.S.D.(least significant differences ) according to Snedecor & Cochran (1980).

Results and discussion

Table (2):Chemical composition of Flaxseed , Flaxseed oil and grease (g/100g)

Items

Flaxseed

Flaxseed oil

Grease

Moisture

7

-

-

Protein

18.3

-

-

Fat

42.2

100

99.5

Carbohydrate

1.3

-

0.5

Ash

3.1

-

 

Total  fiber

27.3

-

 

ω6

5.91

12.70

10.15

ω 3

22.81

53.30

0.99

ω6 : ω3 

1 :.3.8

1 :4.2

10 :1

Table (2) demonstrated the chemical composition of flaxseed, Flaxseed oil and grease of lamb, from the table it could be noticed that the moisture content of Flaxseed was found to be 7%, this result was in agreement with those obtained by Gallo (2013), while protein content was 18.3% this results was slightly lower than those obtained by Gallo (2013), fat content was found to be 42.2%. This result was in agreement with those obtained by Morris, et al (2003), we could noticed that Flaxseed had high content of total fiber being (27.3%) such result was higher than those obtained by Morris, et al (2003) who found that total fiber was 22.8%. with regard to fat content of Flaxseed oil and grease they were 100% and 99.5% respectively as grease of lamb had 0.5%g/100g of ash.

Regarding Omega3  (ω3) results showed that flaxseed oil had the highest content being 53.3g/100g and then came flaxseed (22.8%) while grease had the lowest amount being 0.9 %. with regard to Omega 6 (ω6) , flaxseed oil had the highest content followed by grease then Flaxseed(12.7%,10.15 and 5.9 g/100g).

With regard to ω6: ω3 ratio results showed that the ratio  was 1 : 3.8 and 1 : 4.2 in flaxseed and flaxseed oil respectively while this ratio was 10:1 in grease.

In this respect Simopoulos & Cleland (2003) reported that a high ω6: ω3 ratio promotes pathogenesis of many chronic diseases like cardiovascular disease, cancer, inflammatory and autoimmune disease, rheumatoid ,arthritis, asthma, whereas increased intake of Omega -3 fatty acids (reduced Omega6/Omega3  ratio ) suppresses the effect. Secondary treatment studies have demonstrated a decline in disease progression or reversal of symptoms with decline in ratio.

Flaxseed and flaxseed oil contain high amount of Omega 3 (ω3) Alpha linolenic acid (ALA) and also contain Omega 6 (ω6) with an Omega6: Omega3 ratio of 1:3.8 for flaxseed and 1:4.2 for flaxseed oil.

The high content of ω3 in Flaxseed and Flaxseed oil can affect daily meal balance in ω6 and ω3 ratio.

The high content of ω3 as well as the balance ratio have  anti-inflammatory factor and have an effect on reducing and treatment the risk of many chronic diseases like atherosclerosis, cardiovascular disease, cancer and hyperlipidemia. A balance in  ω6: ω3 intake has always been advocated for optimal health. A part from increase in ω3 intake, there is a need of reduction in absolute ω6 fatty acid intake, in this study we administrated high fat diet (10%animal fat, l0% plant fat) and 2% cholesterol to rats.      

Effect of balance ω6 : ω3 ratio by flaxseed oil (G3) or  flaxseed(G4) on triglyceride level (mg/dl) are shown in table (3)

Table (3): Effect of balance ω6 : ω3 ratio by flaxseed oil (G3) or 3 flaxseed(G4) on triglyceride level (mg/dl)

Time

Treatments

NC

PC

FSO

FS

Zero

68.4 ± 2.4 h

199.8 ± 5.1 a

197.0 ± 3.2 a

195.4 ± 3.6 a

3 weeks

69.8 ± 2.9 gh

157.2 ± 3.3 b

141.0 ± 3.4 c

136.2 ± 3.6 d

6 weeks

73.4 ± 2.1 g

115.0 ± 2.5 e

85.0 ± 2.5 f

81.6 ± 2.1f

NC: Negative control                               PC: Positive control

FSO :Flaxseed Oil group                        FS :Flaxseed      

Regarding data illustrated in table (3) mentioned the effect of treatments on hypercholesterolemic rats with flaxseed oil (G3) or  flaxseed(G4) at zero time., there were a high  significant increase of TG in hypercholesterolemic rats (control + ve group) as compared to healthy group control (– ve) which were (199.8 ± 5.1) and (68.4 ± 2.4) (mg/dl), respectively. All rats fed on flaxseed oil (G3) or  flaxseed(G4) showed  insignificant decreases in TG as compared to control (+ve) group. It is evident that the best treatment was of groups 4 that given flaxseed recorded 195.4 ± 3.6 mg\dl.

The blood lipid profile of rats feeding high fat diet for 6 weeks revealed a great increase in TG for PC group such increase reached about 2 fold (115.0± 2.5) (mg/dl) that of zero time. Regarding G3 and G4 which fed HFD supplemented with FSO and FS  it could be observed that a significant decrease of TG occurred in such groups which were 85.0 ± 2.5 (mg/dl) for G 3 (FSO) and 81.6 ± 2.1for G4 (FS). We could noticed significant difference in triglyceride (TG) of rats in  both G3,G4 and those of PC group. These results suggest that balance ratio of ω6 and ω3 with either fflaxseed or fflaxseed oil had effect in treatment  TG value and improving dyslipidemia.

In this respect , Mishra, (2016)  found that the blood lipid profile of hypercholestremic patients before and after intake of Flaxseed oil revealed a decrease in total cholesterol (TC), triacylglycerol (TG) and change were observed only in TC and TG level with ingestion of 30 ml of Flaxseed oil for a period of 3 months. He also added that there is an evidence that whole Flaxseed may lower serum cholesterol in both normal and hyperlipidemic subjects.

These results agree with Hussein, et al (2014) mentioned that treatment with Flaxseed oil to high cholesterol diet(induced hypercholesterolemia) to rats lowered serum total cholesterol, triacylglycerol, LDL.C, VLDL.C phospholipid, endothelin and homocysteine concentration in addition to increasing HDL. These result suggest that, flaxseed oil may be effective in controlling cholesterolemic status and improving dyslipidemia and has the potential in reducing cardiovascular complications due to hypercholesterolemia.

With regard to Total Cholesterol (mg/dl) in rats fed on the tested diets were illustrated in Table (4).

Table (4): Total Cholesterol (mg/dl) in rats fed on the tested diets

Time

Treatments

NC

PC

FSO

FS

Zero

117.4 ± 4.2 e

225.8 ± 16.2 a

225.8 ± 16.2 a

225.8 ± 16.2 a

3 weeks

118.8 ± 3.9 e

210.0 ± 17.4 b

173.0 ± 8.7 c

179.8 ± 7.9 c

6 weeks

121.8 ± 2.4 e

202.4 ± 4.0 b

120.4 ± 3.0 e

134.2 ± 1.9 d

NC: Negative control                               PC: Positive control

FSO :Flaxseed Oil group                        FS :Flaxseed      

Data recorded in table (4) show the effect of Flaxseed Oil & Flaxseed on total cholesterol ((TC) of hypercholesterolemic Rate. Control (+ve) groups showed significant increase in total cholesterol as compared to healthy rats which were 225.8 ± 16.2 mg /dl and 117.40±2.00 mg/dl, respectively. Rats of Flaxseed Oil & Flaxseed treatments reversed the change occurring in control (+ve) rats leading to decrease TC show significant high decrease and Maximum decrease of total cholesterol recorded for group 3 which fed on Flaxseed Oil.

Our results are in agreement with those obtained by Aly-Aldin et al, (2015) who found that positive control rats had

higher triglyceride and total lipids values than negative control rats and rats fed different replacement levels of flaxseed oil.

Effect of balance ω6 : ω3 ratio by Flaxseed and Flaxseed oil on serum HDL on rats fed HFD are shown in table (5)

Table (5): Effect of balance ω6 : ω3 ratio by Flaxseed and Flaxseed oil on serum HDL on rats fed HFD

Time

Treatments

NC

PC

FSO

FS

Zero

27.8 ± 2.3 e

34.8 ± 2.5 b

26.4 ± 1.1 e

27.6 ± 1.1 e

3 weeks

30.4 ± 3.0 d

32.2 ± 2.3 cd

30.8 ± 0.8 d

32.8 ± 1.9 c

6 weeks

35.0 ± 2.5 b

30.4 ± 1.1 d

40.0 ± 1.0 a

38.4 ± 1.1 a

HFD: high fat high cholesterol diet        HDL: high density lipoprotein

NC: Negative control                               PC: Positive control

FSO :Flaxseed Oil group                        FS : Flaxseed      

The obtained results in table (5) revealed a significant decrease in serum HDL-c  on   rats fed on hypercholesterolemic diet control (+ve group) . All rats of hypercholesterolemia, and fed on Flaxseed Oil group  & Flaxseed showed a significant increase in HDL-c from zero time till 6 weeks as compared to control (+ve) positive group

In this respect ,  Aly-Aldin et al  (2015) mentioned that  Flaxseed oil at different replacement levels resulted in a significant (P≤0.05) increased in HDL values as compared with positive control rats.   These results similar to Khalesi et al (2011) who found that there was a significant increase in blood HDL- C in rats after treatment with 20% raw flaxseed group (3.6% increased) and they found also that in 30% flaxseed group both raw and heated flaxseed group also showed a significant increase in HDL 4.81% and 6% respectively when compared to control group. Also,  Our results are in agreement of those obtained by Mohamed & Afifi (2011) who found that normal rats fed on flaxseed oil have higher significant HDL than control group.

 

Effect of FS and FSO on serum LDL of rats fed   HFD (mg/dl) are shown in table (6)

Table (6): Effect of FS and FSO on serum LDL of rats fed HFD (mg/dl)

Time

Treatments

NC

PC

FSO

FS

Zero

131.6 ± 4.2 f

218.4 ± 14.5 a

212.8 ± 15.4 a

214.2 ± 15.7a

3 weeks

135.0 ± 4.8 ef

212.8 ± 18.1a

175.6 ± 9.6 c

185.4 ± 9.2 b

6 weeks

142.0 ± 3.2 e

209.6 ± 4.3a

143.4 ± 4.0 e

156.8 ± 1.3 d

HFD: high fat high cholesterol diet        LDL: low density lipoprotein

NC: Negative control                               PC: Positive control

FSO :Flaxseed Oil group                        FS :Flaxseed      

The data detected in Table (6) represent the effect of FSO and FS supplementation on serum LDL in rats fed on HFD after 3 and 6 weeks.

From the result it could be noticed that feeding rats on HFD (PC) for 6 weeks, resulting in   significant increase in LDL-c  as compared to normal healthy rats (NC)  at zero time.   Meanwhile, Co-administration of FSO and FS with the high fat diet for the same period led to significant  decrease in LDL level after 6 weeks. On the other hand LDL at NC control showed a little bit of increase in LDL after 6 weeks. These results are in agreement with that's obtained by Mishra (2016) who found that whole Flaxseed powder had profound effect on lowering the blood lipid profile as whole flaxseed powder significantly reduces LDL and TC by 7.66% and 9.7% respectively.

Flaxseeds have received attention for their potential role in treatment lipid disorders. However many people are still unaware of the potential health benefits of Flaxseed and the importance of adjusting the ratio between 3.

These results are in agreement with those obtained by Ali et al (2017) who found that Feeding rats on high cholesterol diet for 12 weeks, resulting in a significant (P> 0.001) increase in serum TG, T.C, LDL and VLDL levels by 3.2, 1.9, 3.0 and 3.2- fold, respectively above the normal levels, a combined with significant (P> 0.001) decrease in HDL by 24.9% as compared to control groups. Meanwhile Co-administration of Flaxseed oil at low dose with HCD for the same period had significantly decreased serum TG, TC, LDL and vLDL levels by 31.0%, 15.6%, 18.0% and 31.0% respectively and a combined with a significant increase in HDL by 3.8% versus HCD fed group. Furthermore, Co- administration of flaxseed oil at double dose cause significantly decreased serum TG, TC, LDL- C and vLDL levels by 57.5%, 37.3%, 47.6% and 57.5% respectively and a combined with a significant increase in HDL by 15.7% versus HCD fed group .

Effect of  balanced 3 ratio with FS and FSO  on weight  gain after 6 weeks are shown in  table (7).

Table (7): Effect of  balanced 3 ratio with FS and FSO on weight  gain after 6 weeks.

Treatments

Initial weight

final weight

% weight gain

NC

176.2 ± 47.6 a

205.2 ± 46.0 a

29± 13.5 b

PC

206.4 ± 32.0 a

240.0 ± 44.6 a

33.6 ± 7.1 a

FSO

219.8 ± 40.4 a

249.2 ± 41.9 a

29.4 ± 19.4b

 FS

232.6 ± 14.2 a

251.0 ± 13.9 a

18.4 ± 2.0 c

NC: Negative control                               PC: Positive control

FSO :Flaxseed Oil group                        FS :Flaxseed

  Result in table (7) showed the initial, final and body weight gain for both negative control fed basal diet(NC) and positive control fed high fat high cholesterol diet (PC) and treated groups fed high fat high cholesterol diet while have adjusting ratio of Omega 6:Omega3 by adding either flaxseed oil (FSO) or flaxseed(FS)  .

From the results we could noticed that PC group recorded the highest  percentage of gain in body weight (33.6%) and there was a significant difference between such group and the other groups. On the other hand no significant differences were noticed between the group of rats fed basal diet (NC) and each of FSO and FS groups which orally administrated with adjusting ratio of ω6: ω3 by Flaxseed oil and Flaxseed which recorded weight gain of 29.4 % and 18.4 % respectively ,such groups had gain in body weight  approxomilty similar to NC group although they were fed high fat diet.

These results agree well with those reported by Aly-Aldin et al  (2015) who  showed that hypercholesterolemic rats fed standard diet (positive control rats) had higher (P≤0.05) body weight gain than normal rats fed standard diet (negative control rats) and hypercholesterolemic rats fed different replacement levels of flaxseed oil diets.

In this respect Mohamed and Afifi (2011) in their study about the effect of FSO on plasma lipid profiles as well as body and organs weight found that there is a significant decrease for body weight gain in  group fed Flaxseed in comparison with control group.

Effect of adjusting ω6 : ω3  ratio flaxseed and flaxseed oil on organs  weight of rat fed high fat diet  are shown in  table (8)

Table (8):Effect of adjusting ω6 : ω 3  ratio flaxseed and flaxseed oil on organs                   weight of rat fed high fat diet

Treatments

liver

relative

spleen

relative

pancreas

relative

NC

4.7 ± 0.76

2.4 ± 0.43

0.8 ± 0.08

0.4 ± 0.07

0.3 ± 0.04

0.2 ± 0.04

PC

6.5 ± 0.51

2.7 ± 0.30

0.9 ± 0.05

0.4 ± 0.05

0.2 ± 0.04

0.1 ± 0.01

FSO

5.5 ± 0.40

2.2 ± 0.28

0.7 ± 0.18

0.3 ± 0.03

0.3 ± 0.03

0.1 ± 0.02

 FS

5.8 ± 0.14

2.3 ± 0.12

0.8 ± 0.11

0.3 ± 0.03

0.3 ± 0.03

0.1 ± 0.01

NC: Negative control                               PC: Positive control

FSO :Flaxseed Oil group                        FS :Flaxseed

 

F0llow Table (8):Effect of adjusting ω6 : ω 3  ratio flaxseed and flaxseed oil on            organs  weight of rat fed high fat diet

Treatments

kidney

relative

heart

relative

brain

relative

NC

1.4 ± 0.20

0.7 ± 0.31

0.7 ± 0.10

0.4 ± 0.05

1.4 ± 0.12

0.7 ± 0.12

PC

1.6 ± 0.18

0.7 ± 0.05

0.7 ± 0.10

0.3 ± 0.04

1.2 ± 0.04

0.5 ± 0.08

FSO

1.5 ± 0.15

0.6 ± 0.13

0.7 ± 0.07

0.3 ± 0.03

1.3 ± 0.05

0.6 ± 0.09

 FS

1.5 ± 0.22

0.6 ± 0.07

0.7 ± 0.04

0.3 ± 0.02

1.4 ± 0.03

0.6 ± 0.02

NC: Negative control                               PC: Positive control

FSO :Flaxseed Oil group                        FS :Flaxseed

The obtained data in table (8) illustrated that there was a decrease in liver weight in G3 and G4 (FSO and FS) compared with  PC. The decrease in liver weight may be due to enhanced of catabolic processes such as glycogenolysis, Lipolysis and proteolysis, these results are in agreement with those obtained by Yadav et al., (2004). Results in the same table showed that there were no significant differences between NC and each of FS and FSO in liver weight, on the other hand there was a significant difference between such groups and PC.

In the same table there were no significant differences among relative weight of each of pancreas and heart in all groups.

However, there were no significant differences among the mean values of relative weights for spleen and kidney in FSO compared with the negative control.

Regarding brain relative weight of FSO and FS, Results showed no significant difference between such groups, while a significant difference was found among FS and each of the negative and positive control. 

Histopathology

Liver of control rats showed normal hepatic parenchyma with normally arranged hepatic cords (fig. 1a) and normal kidney tissue (fig. 2a). Whereas Liver of control +ve group  showed diffuse vacuolar degeneration of hepatocytes (fig. 1b) and sinusoidal leukocytosis. Portal area showed marked congestion of portal blood vessels associated with extensive portal edema, hyperplasia of biliary epithelium and marked thickening of the arteriolar lumen (fig. 1c).

Kidney showed variable histopathological alterations varying from glomerular congestion ( fig. 2b), mesangial expansion with vacuolar degeneration of the surrounding renal tubules ( fig. 2c ) and focal glomerulosclerosis (fig. 2d) . Renal tubules revealed granular  degeneration of their epithelial lining with nuclear pyknosis and intracytoplasmic aggregation of hyaline droplets (fig. 2e), tubular dilatation and intraluminal aggregation of protein cast  (fig. 2f) as well as congestion of intertubular blood capillaries and mild focal interstitial mononuclear cell infiltration associated with perivascular edema.

Group 5 showed alleviated histopathological alterations compared to the control positive group. Liver showed mild vacuolar degeneration of hepatocytes with mild sinusoidal leukocytosis (fig. 1d)  and mild portal edema (fig. 1e). Kideney revealed necrosis of individual cells lining renal tubules (fig. 2g).

Group 10 showed less improved histopathological alterations compared to group 5 as liver showed focal hepatic steatosis (fig. 1f) and sinusoidal leukocytosis and extensive portal edema. Kidney showed mild vacuolar degeneration of some epithelial cells lining renal tubules associated with tubular dilatation (fig. 2h). . 

 

 Fig (1):Liver of the control and treated groups  

 

 

 

 

 

 

 

Fig (2):kidney of  the control and treated groups

 

 

  • References

    • Ali, Z. Y. El-Yamany, M. Tawfeeq, M. and Ahmed, H.H. (2017): Flaxseed oil effectively reduces the risk of development of atherosclerosis in rats fed on high cholesterol diet. Annual Research & Review in Biology 14 (3): 1- 17.
    • Aly-Aldin, M. M., Mansour, E. H., Rahma, E. H., El, A. E. E. B. A., ElBedawey, F. A., & El-Habashy, M. M. (2015). Protective role of flaxseed oil on hypercholesterolemic rats. Biolife, 3, 794-801.‏
    • Albers, N., Benderson, V., &Warnick, G. (1983).Enzymatic  determination of high density lipoprotein cholesterol: Selected Methods. Clin.Chem, 10, 91-99 
    • A.O. A.C. (2016): Association of Analysis Chemists Official methods of analysis of the association of analysis Chemists 18 th edition, Washington. D.C.U.S.A
    • Bancroft, J. D., Stevens, A., & Turner, D. R. (1996). Theory and  Practice of Histological Techniques, 4th edn (New York, Churchill Livingstone).‏
    • Dupasquier, C. M., Weber, A. M., Ander, B. P., Rampersad, P., Steigerwald, S., Wigle, J. T., ... & Lukas, A. (2006). The effects of dietary flaxseed on vascular contractile function and atherosclerosis during prolonged hypercholesterolemia in rabbits. American Journal of Physiology-Heart and Circulatory Physiology.‏
    • Fossati, P. and Principe, L. (1982): Determination of triglycerides. Clinical Chemistry, 28: 2077-2078.
    • Gallo. M. (2013): Preparing and Evaluating some meals high in Essential faulty acids using flaxseed. Thesis Faculty of Agriculture Alexandria University.
    • Gupta, R ., Lakshmy, R., Abraham, R., Reddy, K., Jeemon, P. &Prabhakaran, D. (2013): Serum Omega- 6/ Omega- 3 Ratio and Risk Markers for Cardiovascular Disease in an Industrial population of Delhi Scientific Research, Food Nutrition & Science, (4): 94- 97.
    • Hussein, S.A., El-senosi, Y.A. Ragab. M.R. and Hammad, M.F. (2014): Beneficial effect of Flaxseed oil on lipid metabolism in high cholesterol diet fed rats. Benha Veterinary Medical Journal (BVMJ), 27 (2): 290- 301.
    • ISO (1999): Methylation of Fatty Acids scholar 
    • Khalest, S, Januluddin, R. & Ismail, A. (2011). Effect of Raw and Heated Flaxseed (Linum lisitatissimuml). On Blood lipid profiles in Rats. International Journal of Applied Science and Technology, Vol. 1 No. 4 July.
    • Molena-Fernandes, C. A., Schimidt, G., Neto-Oliveira, E. R., Bersani-   Amado, C. A., & Cuman, R. K. N. (2010). Avaliação dos  efeitos da suplementação com farinha de linhaça (Linumusitatissimum L.) marrom e dourada sobre o perfil lipídico e a evolução ponderal em ratos Wistar. Revista Brasileira de  Plantas Medicinais, 12(2), 201-207  
    • Moss, J. W., & Ramji, D. P. (2016). Nutraceutical therapies for atherosclerosis. Nature Reviews Cardiology, 13(9), 513.‏     
    • Mishra, N. (2016): Effect of whole flaxseed and flaxseed oil in CVD  patient, Health Sciences: An International Journal, 6 (1): 1-7.
    •  Morris, D. H., Vaisey-Genser, M., Thompson, L. U., & Cunnane, S. C. (2003). Availability and labeling of flaxseed food products and supplements. Flaxseed in human nutrition, (Ed. 2), 404-422.
    • Mohamed, M.S. and Afifi, A.A. (2011): Effect of some polyunsaturated fatty acids rich-oils on plasma lipid profiles using normal rats. J. Agric- Chem. and Biotechn. Mansoura Uni. 2 (2): 49-59.
    • Newairy, A. S. A., & National Institutes’ Health(2012):U.S department of health and human services Abdou, H. M. (2009). Protective role of flax lignans against lead acetate induced oxidative damage and hyperlipidemia in rats. Food and Chemical Toxicology, 47(4), 813-818.

    Herbs at a glance . www.ncbi.n/m.nih.gov/pubmed

    • Lee, R. and Nieman, D. (1996): Nutrition Assessment. 2nd Ed. Mosby, Missouri, USA. 591 – 594.
    • Prasad, K. (2005). Hypocholesterolemic and antiatherosclerotic effect of flax lignan complex isolated from flaxseed. Atherosclerosis, 179(2), 269-275.‏
    • Ruel. I.;Brisson, D .; Aljenedil, S .; Awan, Z.; Baass, A .; Bélanger, A.; Bergeron, J., Bewick. D.; Brophy, J.M.; Brunham, L.R.; Couture, P.; , Dufour, R.; Francis, G.A.; Frohlich,J.; Gagné,  C.; Gaudet,D.; Grégoire, J.C.; Mancini, G.B..;McCrindle, B.W.; Pang, J.; Raggi, P.; Tu,  J.V.;Watts, G.F. and Genest, J.; (2018): Simplified CanadianDefinition forFamilial Hypercholesterolemia Can J  Cardiol. .05.015.
    • Simopoulos, A.  (2016): An increase in the Omega- 6/ Omega- 3 Fatty acid ratio increase the risk of obesity. Nutrients: 8 (128): dot: 10. 3390/ nu 8030128.
    • Sammour, R. H. (1999). Proteins of linseed (Linum usitatissimum L.), extraction and characterization by electrophoresis. Botanical Bulletin of Academia Sinica, 40.‏
    • Simopoulos, A. P., & Cleland, L. G. (2003). Subject Index. In Omega-6/Omega-3 Essential Fatty Acid Ratio: The Scientific Evidence (Vol. 92, pp. 170-174). Karger Publishers.
    • Snedecor , G.W  and Cochran, W.G. (1980).Statistical methods. Oxford and J.B.H publishing Con .7 th  edition. pp1-172.
    • Thomas, L. (1992): Labor and Diagnose. 4th Edition, Die Medizinische Verlagsgesellschachft, Margurg. advances in bioscience and biotechnology, Vol.6 No.4.
    • Yadav, J. S., Wholey, M. H., Kuntz, R. E., Fayad, P., Katzen, B. T., Mishkel, G. J. & Popma, J. J. (2004). Protected carotid-artery stenting versus endarterectomy in high-risk patients. New England Journal of Medicine, 351(15), 1493-1501.
    • WHO. World Health Organization Fact Sheet 317; 2015.Available:http://www.who.int/mediacentre/factsheets/fs317/en/
    • Whelan, J., & Rust, C. (2006). Innovative dietary sources of n-3 fatty acids. Annu. Rev. Nutr., 26, 75-